Tearing Down The Goalposts Whats Next For US FDA Diabetes Guidelines
Tearing Down The Goalposts: What’s Next For US FDA Diabetes Guidelines?
09:57 EDT 30 Oct 2018 |
SCRIP
Advisory committee discussion of cardiovascular safety standards for type 2 diabetes therapies was a friendly, collegial event with broad agreement...
More From BioPortfolio on "Tearing Down The Goalposts: What’s Next For US FDA Diabetes Guidelines?"